Berns Paul L

Neumora Therapeutics, Inc. Common Stock · See Remarks

Berns Paul L is listed in public filings as director, officer: See Remarks. This Berns Paul L insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Neumora Therapeutics, Inc. Common Stock (NMRA), and Metsera, Inc. (MTSR). Investors use Berns Paul L's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Neumora Therapeutics, Inc. Common StockNMRA$26M7.4M sharesSellFeb 17, 2026$34.5K9.8k shares$3.51--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Neumora Therapeutics, Inc. Common StockNMRA$3.8M1.7M sharesGrant / ExerciseJan 8, 2026$3.8M1.7M shares$2.33--
Metsera, Inc.MTSR$0223.4k sharesOtherNov 13, 2025$1.8M223.4k shares$8.18--
Metsera, Inc.MTSR$024.2k sharesOtherNov 13, 2025$707.5K24.2k shares$29.25--
Metsera, Inc.MTSR$0957.6k sharesOtherNov 13, 2025$10957.6k shares$0.00--
Metsera, Inc.MTSR--4k sharesGrant / ExerciseNov 13, 2025Disclosure amount unavailable4k shares----
Neumora Therapeutics, Inc. Common StockNMRA$02M sharesOtherMay 28, 2025$3.4M2M shares$1.69--
Neumora Therapeutics, Inc. Common StockNMRA$1.4M2M sharesGrant / ExerciseMay 28, 2025$1.4M2M shares$0.72--
Neumora Therapeutics, Inc. Common StockNMRA$688k955.9k sharesGrant / ExerciseMay 28, 2025$688.2K955.9k shares$0.72--
Neumora Therapeutics, Inc. Common StockNMRA$358k497k sharesGrant / ExerciseMay 28, 2025$357.9K497k shares$0.72--
Neumora Therapeutics, Inc. Common StockNMRA$247k342.5k sharesGrant / ExerciseMay 28, 2025$246.6K342.5k shares$0.72--
Metsera, Inc.MTSR$707k24.2k sharesGrant / ExerciseMay 20, 2025$707.5K24.2k shares$29.25--
Neumora Therapeutics, Inc. Common StockNMRA$13M7.4M sharesSellFeb 18, 2025$23.5K13.9k shares$1.69--
Neumora Therapeutics, Inc. Common StockNMRA$0342.5k sharesOtherFeb 13, 2025$6.2M342.5k shares$18.07--
Neumora Therapeutics, Inc. Common StockNMRA$0955.9k sharesOtherFeb 13, 2025$6.1M955.9k shares$6.36--
Neumora Therapeutics, Inc. Common StockNMRA$3.4M2M sharesGrant / ExerciseFeb 13, 2025$3.4M2M shares$1.69--
Neumora Therapeutics, Inc. Common StockNMRA$0497k sharesOtherFeb 13, 2025$2.3M497k shares$4.63--
Neumora Therapeutics, Inc. Common StockNMRA$1.6M955.9k sharesGrant / ExerciseFeb 13, 2025$1.6M955.9k shares$1.69--
Neumora Therapeutics, Inc. Common StockNMRA$840k497k sharesGrant / ExerciseFeb 13, 2025$840.0K497k shares$1.69--
Neumora Therapeutics, Inc. Common StockNMRA$579k342.5k sharesGrant / ExerciseFeb 13, 2025$578.8K342.5k shares$1.69--
Neumora Therapeutics, Inc. Common StockNMRA--7.4M sharesGrant / ExerciseDec 27, 2024Disclosure amount unavailable133.1k shares----
Berns Paul L | TradingNote